BIND Company Details: 437 Social Audience

BIND Overview

Headquarters: London, City of, United Kingdom
Website: www.bindproject.eu
Industry: Research Services
Employees: 126
Founded: 2020
NAICS: Scientific Research and Development Services

Research and Development in the Physical, Engineering, and Life Sciences

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Keywords

research rare disease muscular dystrophy MRI science technology neuroscience neuropsychology H2020 neuromuscular ADHD ADD

About BIND

The BIND project’s ambition is to elucidate the role of dystrophin in the brain. This protein is deficient in Duchenne muscular dystrophy (DMD) and only partly functional in Becker muscular dystrophy (BMD). The project aims to develop new outcome measures that could inform the field for future clinical trials and will promote more rigorous assessment and intervention of brain comorbidities. The ultimate goal of this project is to improve understanding and measurement of dystrophin in the brain, thus working towards better treatments, care and outcomes for all those living with DMD and BMD.